Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

Data from iPrEx Open-Label Extension (OLE) Demonstrate High Interest in PrEP, Longer-term Evidence of Safety and Efficacy, and No Sign of Increased Risk Behavior Among PrEP Users
International team sheds new light on biology underlying schizophrenia
US Patent Office Grants McCord Research Endothelial Cell Treatment Patent
Puregraft® Filtration for Autologous Fat Transfer Demonstrates Significantly Higher Long-Term Retention Compared to Centrifuged Controls
ADB International Group Inc. Announces Partnership with Austen BioInnovation Institute to Bring E-QURE BST™ Wound Healing Device to U.S. Market
Innocutis Introduces Sitavig® 50mg (ACYCLOVIR) Muco-Adhesive Buccal Tablet For Relief From Herpes Labialis (Cold Sores)
Maxwell Biotech Venture Fund's Portfolio Company MetaMax Announces Enrollment of First Patients in Phase 1/2a Clinical Trial of its Lead Anticancer Drug MM-D37K
Syneron Receives China CFDA Clearance for elure™ Advanced Skin Brightening Lotion
Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor English
Dipexium Pharmaceuticals Initiates Second of Two Pivotal Phase 3 Clinical Trials of Locilex® in Patients with Mild Infections of Diabetic Foot Ulcers
Celsion Corporation Announces $1 Million NIH, NIBIB - Career Development Award Grant for Glioblastoma Research with ThermoDox® and HIFU
Expanding Orthopedics Inc. has obtained FDA Clearance for its FLXfit™, the world's first 3D expandable interbody cage
Braeburn Pharmaceuticals Enrolls First Patients In Late-Stage Clinical Study Of Probuphine® For Opioid Dependence
CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China
Sequenom Laboratories Expands International Noninvasive Prenatal Testing Services To Broader Population With VisibiliT™ Test
High-Viscosity Glass Ionomers May Be a Viable Alternative for Placing Tooth Restorations and Sealing Dental Pits and Fissures
Two-Year Results From Phase 3 VIVID-DME Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Prana Alzheimer's disease Development Program update
aTyr, The Hong Kong University of Science and Technology, The Scripps Research Institute and Stanford University Join in the Discovery of a New Class of Human Proteins
Shire Reports Top-Line Results From Two Head-to-Head Studies Comparing Vyvanse® (lisdexamfetamine dimesylate), CII, With Concerta® (methylphenidate HCl), CII, in Adolescents with ADHD
JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
$2.5 Million Grant Will Establish Patient-Centered Outcomes Research Training Program At Einstein And Montefiore
BiologicTx® Selected As The Specialty Pharmacy For Prospective, Global, Multi-Center, Observational Treatment Registry Study Of Intravenous Immunoglobulin Maintenance Therapy In Alloantibody Positive Renal Allograft Recipients
ViaCyte Files Investigational New Drug Application and Device Master File with FDA for Novel Cell Replacement Therapy Product Candidate Designed to Treat Patients with Type 1 Diabetes
Dipexium Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Locilex® in Patients with Mild Infections of Diabetic Foot Ulcers
Dipexium Pharmaceuticals Announces Successful Completion of Phase 1 Skin Irritation Trial of Locilex®
Ruthigen Treats First Human Subjects In Clinical Trial For RUT58-60
Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a)
Helsinn Group and Chugai Pharma Marketing Enter Into Agreement for Marketing Rights of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) in the UK and Ireland and for Palonosetron Monotherapy in the UK
Alzheimer%s Disease Global Clinical Trials Review, H1, 2014 English
Phobia Global Clinical Trials Review, H1, 2014
TauRx Therapeutics Achieves Enrollment Target in the First of Its Two Phase III Clinical Trials of LMTX™ in Alzheimer's Disease
Silk Road Medical Completes Enrollment In The ROADSTER Clinical Trial For Carotid Artery Disease
Biotie Therapies Selects Bracket's CDR System™ for Phase 2 Trial of Treatment of Parkinson's Disease
FDA Grants Astellas Qualified Infectious Disease Product Designation for Isavuconazole for the Treatment of Invasive Candidiasis
Decline in Prescription Drug Misuse More than Twice as High in States with Broad Drug Abuse Prevention Programs, New Quest Diagnostics Health Trends Study Finds English
Contract Research Organization WCCT Global Announces Huge Success in Large Phase I Clinical Research Program English
ImQuest Pharmaceuticals Receives FDA Approval to Initiate Clinical Trials of a Vaginal Gel for the Prevention of HIV Transmission to Women
Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data
Avanir Pharmaceuticals Announces Presentation of Positive Early Results from PRISM II Study
Rigel Initiates Phase 3 Studies of Fostamatinib in ITP
ChromaDex Initiates First Human Clinical Study to Confirm ChromaDex's NIAGEN™ Nicotinamide Riboside Will Increase NAD+
New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease
NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT
Adynxx Initiates Phase 2 Dose-Ranging Study of AYX1, Lead Compound for the Prevention of Post-Surgical Pain
Resolve Initiates Phase 2 Clinical Study in SLE
Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy) English Spanish Portuguese Spanish
Lilly and Immunocore Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies
Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx
Gertler Family Foundation advances sickle cell disease research and care in Democratic Republic of the Congo

< Prev Next >
PR Newswire - United Business Media